AI software shows promising results in detecting breast cancer missed by doctors

A doctor looks at the results of a mammogram.
(Image credit: Anne-Christine Poujoulat/AFP via Getty Images)

In Hungary, early testing results show that artificial intelligence has an "impressive ability" to detect signs of breast cancer missed by doctors, The New York Times reports.

Dr. Edith Karpati, a radiologist, told the Times that when looking at hundreds of X-rays a day, "it's so easy to miss tiny lesions." Her son, Peter Kecskemethy, is the co-founder of Kheiron Medical Technologies, an AI software company that aims to assist doctors screening for breast cancer. The AI systems are fed millions of mammograms of patients whose diagnoses are known, as well as images labeled by radiologists to teach the AI to detect cancerous growths by their shapes, locations, and density, the Times reports. By then creating a mathematical representation of normal mammograms and those with cancers, the system compares that baseline to spot abnormalities in mammograms.

In 2022, after testing more than 275,000 breast cancer cases, Kheiron said its AI technology can spot cancer at least as well as doctors as the second reader of scans, and reduced the workload of radiologists by at least 30 percent. Additional testing at a clinic in Hungary found the AI software was able to identify more malignancies, increasing the cancer detection rate by 13 percent. "It's a huge breakthrough," Dr. András Vadászy, director of the MaMMA Klinika, told the Times. "If this process will save one or two lives, it will be worth it."

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

The technology is meant to be used alongside doctors, not to replace them, and more clinical trials are needed so the systems can produce accurate results on women of all ages, ethnicities, and body types.

Catherine Garcia, The Week US

Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.